


Find new investment opportunities based on Market Sentiment Indicator. Manage watchlist risk with leading indicator of volatility See what influential analysts and investors are saying about stocks in My Watchlist
Most Trending
-2.13%
+0.69%
-2.08%
+0.82%
-8.52%
TRVI
Trevi Therapeutics Inc.
$13.44
Strengths

Upgraded on attractively valued

Outperform the market

Earnings are forecast to grow
TRVI Price Performance
$11.01 (+22.07%)
$9.75 (+37.85%)
$6.71 (+100.30%)
$4.15 (+223.86%)
TRVI has Low risk level based on volatility, sector strength, volume, investor confidence, and outlook.
Click here to check what is your level of risk

TRVI overall standing based on key factors, offering insights into analysts perspectives and market expectations.
Hover over the category for more information
Earnings
Earnings
Rating
Rating

Upgraded on attractively valued
Momentum
Momentum
Activity
Activity
Future
Future

Outperform the market

Earnings are forecast to grow
![]()
TRVI Analysts opinion is positive and also has improved from the past 3 months
Analysts perspectives on the stock desirability, trend direction, and growth potential
TRVI Street Sentiment is extremely bullish and have positive views on the near-term outlook
Average key support and resistance price levels
Login to displayWhat is TRVI current stock price?
What are TRVI stock strengths?
What is TRVI Risk Level?
What is TRVI market cap and volume?
What is TRVI current Stock IQ?
Should I buy TRVI stock right now?
Is TRVI a Strong Buy right now?
What does a 'Strong Buy' rating mean for TRVI?
What does a 'Strong Sell' rating mean for TRVI?
What factors influence TRVI's Stock IQ?
Join over 10,000+ subscribers who value exclusive insights. Stay ahead in the stock market! Enter your email for daily alerts
Stay ahead of the market
Market trends
Investment tips
Market analysis service
Future potential
Informed investment decisions
Investment analysis
IInvestment strategies
In-depth stock analysis
Performance analysis
Stock market insights
Financial trends analysis
Most Trending
-2.13%
+0.69%
-2.08%
+0.82%
-8.52%
TRVI
Trevi Therapeutics Inc.
Current Price
$13.44
Stock Insights
Strengths

Upgraded on attractively valued

Outperform the market

Earnings are forecast to grow

TRVI Price Performance
$11.01 (+22.07%)
$9.75 (+37.85%)
$6.71 (+100.30%)
$4.15 (+223.86%)
TRVI Analysts Opinion
TRVI Overall standing by considering key factors, reflecting analysts perspectives and market expectations.
Hover over the category for more information
Earnings
Earnings
Rating
Rating

Upgraded on attractively valued
Momentum
Momentum
Activity
Activity
Future
Future

Outperform the market

Earnings are forecast to grow
![]()
TRVI Analysts opinion is positive and also has improved from the past 3 months
Analysts perspectives on the stock desirability, trend direction, and growth potential
TRVI Street Sentiment is extremely bullish and have positive views on the near-term outlook
TRVI has Low risk level based on volatility, sector strength, volume, investor confidence, and outlook.
Click here to check what is your level of risk

Average key support and resistance price levels
TRVI Stock IQ
TRVI Latest Analysis
Trevi Therapeutics appoints new CFO.
Thu Dec 4, 2025
Trevi Therapeutics: Buy Rating For Haduvio Treating Chronic Cough In IPF And Beyond.
Wed Dec 3, 2025
Trevi Therapeutics edges higher amid takeover speculation.
Tue Dec 2, 2025
Chronic Refractory Cough Market is Expected to Boom by 2034 Driven by Advancements in Treatment Options | DelveInsight. Chronic Refractory Cough Market is Expected to Boom by 2034 Driven by Advancements in Treatment Options |. DelveInsightThe chronic refractory cough market is expected to grow due to a rising diagnosed patient pool greater awareness and recognition of chronic cough as a distinct condition limitations of current off-label treatments and the anticipated launch of emerging ther
Mon Nov 24, 2025
Leerink Partners Maintains Trevi Therapeutics (TRVI) Outperform Recommendation. Fintel reports that on November 20 2025 Leerink Partners maintained coverage of Trevi Therapeutics (NasdaqGM:TRVI) with a Outperform recommendation. Analyst Price Forecast Suggests 89.15% Upside
Fri Nov 21, 2025
FIND US ON
Unlock the knowledge that 10,000+ subscribers already cherish. Join for exclusive insights and stay ahead in the stock game! Enter your email to receive daily alerts
In-depth stock analysis
Informed investment decisions
Stock market insights
Stock trading tips
TRVI Stock trends
TRVI Stock performance
TRVI Stock analysis
TRVI investment strategies
Disclaimer:
Past performance, whether from actual results or historical strategy tests, does not guarantee future success. The displayed outcomes are based on strategies not previously available to investors and do not depict the returns achieved by any specific investor.
The Readiness Indicators, Sentiment Indicators, and overall score are derived from a model retrospectively applied using historical data. This model relies on assumptions inherent to it, which may or may not be verifiable and carry potential risks, including losses.
Engaging in active trading may not be suitable for individuals with limited resources, minimal investment or trading experience, or a low-risk tolerance. Proceed with caution as your capital is exposed to risks.
Please note that no offer or solicitation to buy or sell securities, securities derivatives of future products of any kind, or any type of trading or invesment advise, recommendation or strategy, is made, given or endorsed by StocksRunner including any of their affiliates ("TS").
This information is provided for illustrative purposes only. You should not rely on any advice and/or information contained in this website and before making any investment decision. we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice.